Deborah L. Weitzman
Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cardinal Health Inc (CAH) | Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment | $741,932 | $5,507,857 |
| 2024 | Cardinal Health Inc (CAH) | Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment | $709,153 | $5,085,987 |
| 2023 | Cardinal Health Inc (CAH) | Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment | $606,139 | $4,070,451 |
Earnings-call appearances
No earnings-call appearances recorded yet.